ARCHIVES

Did Iressa Data Merit Approval? Experts Discuss Implications For Drug Development, Lung Cancer Treatment, Reimbursement (12-page issue).

This article is from The Cancer Letter archive.

Vol. 29 No. 19 | May 9, 2003

Download PDF Visit The Full Archive

Related Articles

Nobel Laureate Gilman Prepares to Leave The Texas Cancer Agency—Can it Survive?

September 28, 2012

Wall Street Analyst Who Sounded Alarm Over Prostate Cancer Drug Provenge In JNCI Settles With SEC Over Shorting Dendreon Stock

December 17, 2013

HPV Vaccines Should Be Priority, Say President’s Cancer Panel

March 7, 2014

Two Drugs Slow Progress Of Metastatic Prostate Cancer

June 29, 2001

MacFarlane, Frelick to Speak At Seminar

July 22, 1983

HHS Approves States Plans For Breast, Cervical Cancer Treatment For Uninsured.

April 6, 2001